Status
Conditions
Treatments
About
A two months intervention in which two groups of cognitive disorders, Parkinson and Alzheimer's disease, will receive 50g/day of a commercial MCT supplement combined with supervised aerobic exercise 3 times/week. Cognition and ketones will be assess before and after the intervention, along with endocannabinoids plasma concentrations.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
14 participants in 2 patient groups
Loading...
Central trial contact
Mélanie Fortier, M.Sc.; Valérie St-Pierre, M.Sc.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal